# Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women

> **NCT01987804** · PHASE2 · COMPLETED · sponsor: **PepTonic Medical AB** · enrollment: 64 (actual)

## Conditions studied

- Vaginal Atrophy

## Interventions

- **DRUG:** Oxytocin 100 i.u.
- **DRUG:** Oxytocin 400 i.u.
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01987804
- **Lead sponsor:** PepTonic Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01987804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01987804, "Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01987804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*